Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AloCelyvir in Metastatic Uveal Melanoma
NCT05047276Phase 2Unknown
- Start
- Oct 2021
- Primary completion
- Jun 2023
- Modality
- Oncolytic Viruses, Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of AloCelyvir in Uveal melanoma (UM). Status: unknown.
02
Drugs
AloCelyvir
03
Conditions
Uveal melanoma (UM)
Beyond the preview
Go deeper on NCT05047276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05047276.